USPTO serial 98559594
TETRAMAB
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- COLLIER, DAVID E
- Law office
- TMEG LAW OFFICE 109
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with TETRAMAB?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christopher D. Olszyk, Jr.
Christopher D. Olszyk, Jr. Fox Rothschild LLP997 Lenox Drive, Bldg. 3Lawrenceville, NJ 08643-2311United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Multitarget, multiepitope, multivalent centralized antibody molecule structure used to incorporate multiple target antigen binders into a single antibody, namely, multi-specific therapeutic antibodies for scientific and medical research | ACTIVE | — |
| 005 | Multitarget, multiepitope, multivalent centralized antibody molecule structure used to incorporate multiple target antigen binders into a single antibody, namely, multi-specific reagent antibodies for medical diagnosis purposes | ACTIVE | — |
| 016 | Printed educational and informational publications related to cancer, immunological, inflammatory and neurological disorders, namely, pamphlets, newsletters, guides | ACTIVE | — |
| 042 | Providing prescription drug research information relating to drugs for the diagnosis and treatment of cancer, immunological, inflammatory and neurological disorders | ACTIVE | — |
| 044 | Providing healthcare information regarding the treatment of cancer, immunological, inflammatory and neurological disorders; Providing healthcare information regarding drugs for the treatment of cancer, immunological, inflammatory and neurological disorders | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Aarvik Therapeutics, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 016
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named TETRAMAB
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 5, 2025 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 5, 2025 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 6, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 6, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 6, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 4, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 22, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 20, 2024 | NWAP | NEW APPLICATION ENTERED | — |